GRK2-Dependent Desensitization Downstream of G Proteins

REFERENCES

• Jacoby E, Bouhelal R, et al. The 7 TM G-protein-coupled receptor target family. Chem Med Chem 2006; 1: 761–782
   Web of Science ®Google Scholar
• Pierce K L, Premont R T, et al. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002; 3: 639–650
   PubMed Web of Science ®Google Scholar
• Spiegelberg B, Hamm D HE. Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription. Curr Opin Genet Dev 2007; 17: 40–44
   PubMed Web of Science ®Google Scholar
• Premont R, Gainetdinov T RR. Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 2007; 69: 511–534
   PubMed Web of Science ®Google Scholar
• Moore C AC, Milano S K, et al. Regulation of Receptor Trafficking by GRKs and Arrestins. Annl Rev of Physiol 2007; 69: 451–482
   PubMed Web of Science ®Google Scholar
• DeWire S M, Ahn S, et al. beta-Arrestins and Cell Signaling. Annl Rev of Physiol 2007; 69: 483–510
   PubMed Web of Science ®Google Scholar
• Hupfeld C, Olefsky J JM. Regulation of Receptor Tyrosine Kinase Signaling by GRKs and beta-Arrestins. Annl Rev of Physiol 2007; 69: 561–577
   PubMed Web of Science ®Google Scholar
• Ribas C, Penela P, et al. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta 2007; 1768: 913–922
   PubMed Web of Science ®Google Scholar
• Pitcher J A, Touhara K, et al. Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G beta gamma subunits and lipid. J Biol Chem 1995; 270: 11707–11710
   PubMed Web of Science ®Google Scholar
• Palczewski K, Buczylko J, et al. Identification of the N-terminal region in rhodopsin kinase involved in its interaction with rhodopsin. J Biol Chem 1993; 268: 6004–6013
   PubMedGoogle Scholar
• Ferguson S S. Phosphorylation-independent attenuation of GPCR signalling. Trends Pharmacol Sci 2007; 28: 173–179
   PubMed Web of Science ®Google Scholar
• Murga C, Ruiz-Gomez A, et al. High affinity binding of beta-adrenergic receptor kinase to microsomal membranes. Modulation of the activity of bound kinase by heterotrimeric G protein activation. J Biol Chem 1996; 271: 985–994
   PubMedGoogle Scholar
• Naga Prasad S V, Laporte S A, et al. Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol 2002; 158: 563–575
   PubMed Web of Science ®Google Scholar
• Lodowski D T, Pitcher J A, et al. Keeping G proteins at bay: a complex between G protein-coupled receptor kinase 2 and Gbetagamma. Science 2003; 300: 1256–1262
   PubMed Web of Science ®Google Scholar
• Tesmer V M, Kawano T, et al. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science 2005; 310: 1686–1690
   PubMedGoogle Scholar
• Penela P, Murga C, et al. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. Cardiovasc Res 2006; 69: 46–56
   PubMed Web of Science ®Google Scholar
• Vroon A, Heijnen C J, et al. GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 2006; 80: 1214–1221
   PubMed Web of Science ®Google Scholar
• Raman M, Chen W, et al. Differential regulation and properties of MAPKs. Oncogene 2007; 26: 3100–3112
   PubMed Web of Science ®Google Scholar
• Cuenda A S. Rousseau. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 2007; 1773: 1358–1375
   PubMed Web of Science ®Google Scholar
• Dhillon A S, Hagan S, et al. MAP kinase signalling pathways in cancer. Oncogene 2007; 26: 3279–3290
   PubMed Web of Science ®Google Scholar
• Jimenez-Sainz M C, Fast B, et al. Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation. Mol Pharmacol 2003; 64: 773–782
   PubMedGoogle Scholar
• Kleibeuker W, Jurado-Pueyo M, et al. Physiological changes in GRK2 regulate CCL2-induced signaling to ERK1/2 and Akt but not to MEK1/2 and calcium. J Neurochem Feb, 2008; 104(4)979–992
   PubMedGoogle Scholar
• Peregrin S, Jurado-Pueyo M, et al. Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Curr Biol 2006; 16: 2042–2047
   PubMed Web of Science ®Google Scholar
• Mayor F, Jr, Jurado-Pueyo M, et al. Interfering with MAP kinase docking interactions: implications and perspective for the p38 route. Cell Cycle 2007; 6: 528–533
   PubMed Web of Science ®Google Scholar
• Sharrocks A D, Yang S H, et al. Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem Sci 2000; 25: 448–453
   PubMed Web of Science ®Google Scholar
• Shi Z, Resing K A, et al. Networks for the allosteric control of protein kinases. Curr Opin Struct Biol 2006; 16: 686–692
   PubMed Web of Science ®Google Scholar
• Chang C I, Xu B E, et al. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell 2002; 9: 1241–1249
   PubMed Web of Science ®Google Scholar
• Murga C, Esteban N, et al. The basal subcellular distribution of beta-adrenergic receptor kinase is independent of G-protein beta gamma subunits. FEBS Lett 1997; 409: 24–28
   PubMedGoogle Scholar
• New L, Han J. The p38 MAP kinase pathway and its biological function. Trends Cardiovasc Med 1998; 8: 220–228
   PubMed Web of Science ®Google Scholar
• Petrich B, Wang G Y, Stress-activated M AP. kinases in cardiac remodeling and heart failure; new insights from transgenic studies. Trends Cardiovasc Med 2004; 14: 50–55
   PubMedGoogle Scholar
• Communal C, Colucci W S, et al. Reciprocal modulation of mitogen-activated protein kinases and mitogen- activated protein kinase phosphatase 1 and 2 in failing human myocardium. J Card Fail 2002; 8: 86–92
   PubMedGoogle Scholar
• Kumar S, Boehm J, et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2: 717–726
   PubMed Web of Science ®Google Scholar
• Lombardi M S, Kavelaars A, et al. Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol 2001; 166: 1635–1640
   PubMed Web of Science ®Google Scholar
• Lombardi M S, Kavelaars A, et al. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis. Faseb J 1999; 13: 715–725
   PubMed Web of Science ®Google Scholar
• Vroon A, Kavelaars A, et al. G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis. J Immunol 2005; 174: 4400–4406
   PubMed Web of Science ®Google Scholar
• Kobilka B, Deupi K X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 2007; 28: 397–406
   PubMed Web of Science ®Google Scholar